|
- Metastatic (stage 4) prostate cancer - Mayo Clinic
Metastatic prostate cancer diagnosis often involves blood tests and imaging tests A metastatic prostate cancer is an advanced cancer that has spread to other parts of the body This makes it a stage 4 prostate cancer A prostate-specific antigen test measures the amount of prostate-specific antigen
- What to know about metastatic prostate cancer
Metastatic, or stage IV, prostate cancer is prostate cancer that has spread outside of the prostate to other parts of the body Genitourinary medical oncologist Bilal Siddiqui, M D , who treats patients with advanced prostate cancer, talks about prognosis and treatment advances
- Metastatic Prostate Cancer—A Review of Current Treatment . . .
Prostate cancer is the most common tumor in men Although there have been many new developments in the last few years, metastatic castration resistant prostate cancer remains a deadly disease This article provides an overview of currently approved
- Advanced Prostate Cancer Treatment Options - WebMD
Cancer that spreads outside the prostate gland to the lymph nodes, bones, or other areas is called metastatic prostate cancer Currently, no treatments can cure advanced prostate cancer
- Metastatic Prostate Cancer: Updates in Management
The landscape of metastatic prostate cancer treatment is rapidly changing, with novel drugs and approaches offering promise for improved outcomes
- Treating advanced prostate cancer - Harvard Health
Men whose prostate cancer has become aggressive have several treatment options available These include different combinations of radiation, surgery, androgen deprivation therapy, chemotherapy, immunotherapy, and anti-androgens
- Treatment for Metastatic Prostate Cancer Often Suboptimal
In most people with metastatic hormone-sensitive prostate cancer, the cancer eventually changes so that it can grow without being reliant on testosterone from the testes, known as hormone-resistant (or castration-resistant) disease
- METASTATIC PROSTATE CANCER HANDBOOK
Background Incorporating insights from the Association of Cancer Care Centers (ACCC) member multidisciplinary focus groups and relevant literature to spotlight barriers, this handbook offers solutions, tools, and resources for providers and patients concerning genetic testing for metastatic prostate cancer
|
|
|